HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal sepsis: evaluation and management.

Abstract
Bacterial antigenic challenge presents a difficult fight for the neonatal immune system, and they have a smaller arsenal of weapons to fight bacterial infections than adults and older children. The baby's own systemic inflammatory response may have detrimental effects on several organs and longer lasting effects on the developing brain. Neurodevelopmental outcomes after maternal chorioamnionitis are worse than neonates without a contaminated intrauterine environment, regardless of gestation age and the baby's culture results. Successes with intrapartum antibiotic prophylaxis decreasing rates of GBS sepsis and maternal chorioamnionitis, have heartened care providers and parents. These results demonstrate the advances possible when specific diseases are made a national health priority, and good clinical trial work is applied to clinical practice.
AuthorsDorothea Jenkins Eicher, David J Annibale
JournalJournal of the South Carolina Medical Association (1975) (J S C Med Assoc) Vol. 98 Issue 3 Pg. 106-12 (Jun 2002) ISSN: 0038-3139 [Print] United States
PMID12125192 (Publication Type: Journal Article, Review)
Topics
  • Humans
  • Infant, Newborn
  • Neonatology
  • Population Surveillance
  • Practice Guidelines as Topic
  • Sepsis (blood, diagnosis, drug therapy)
  • Streptococcal Infections (prevention & control)
  • Streptococcus agalactiae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: